DIVISLAB.NS
Divi's Laboratories Ltd
Price:
6,081
INR
Volume:
759,310
India | Life Sciences Tools & Services
Discounted Cash Flow
Trading Multiples
Peter Lynch Fair Value
Earnings Power Value
Dividend Discount Model
WACC
DIVISLAB.NS Intrinsic Value
-84.9 %
Upside
What is the intrinsic value of DIVISLAB.NS?
As of 2025-05-14, the Intrinsic Value of Divi's Laboratories Ltd (DIVISLAB.NS) is 918.99 INR. This DIVISLAB.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 6,081.00 INR, the upside of Divi's Laboratories Ltd is -84.9%.
The range of the Intrinsic Value is 735.84 - 1,278.43 INR.
Is DIVISLAB.NS undervalued or overvalued?
Based on its market price of 6,081.00 INR and our intrinsic valuation, Divi's Laboratories Ltd (DIVISLAB.NS) is overvalued by 84.9%.
6,081.00 INR
Stock Price
918.99 INR
Intrinsic Value
| Range | Selected | Upside | ||
| a | ||||
| DCF (Growth Exit 5Y) | 735.84 - 1,278.43 | 918.99 | -84.9% | |
| DCF (Growth Exit 10Y) | 987.04 - 1,739.18 | 1,243.29 | -79.6% | |
| DCF (EBITDA Exit 5Y) | 2,445.02 - 4,083.7 | 3,226.43 | -46.9% | |
| DCF (EBITDA Exit 10Y) | 2,242.47 - 4,192.26 | 3,102.37 | -49.0% | |
| Peter Lynch Fair Value | 692.2 - 692.2 | 692.2 | -88.62% | |
| P/E Multiples | 2,005.63 - 2,610.81 | 2,332.03 | -61.7% | |
| EV/EBITDA Multiples | 1,756.84 - 3,123.79 | 2,362.14 | -61.2% | |
| Earnings Power Value | 501.6 - 640.48 | 571.04 | -90.6% | |
| Dividend Discount Model - Stable | 419.27 - 1,061.66 | 740.46 | -87.8% | |
| Dividend Discount Model - Multi Stages | 831.6 - 1,606.14 | 1,092.78 | -82.0% | |
| Market Cap (mil) | 1,614,323 |
| Beta | 0.81 |
| Outstanding shares (mil) | 265 |
| Enterprise Value (mil) | 1,578,383 |
| Market risk premium | 8.8% |
| Cost of Equity | 13.8% |
| Cost of Debt | 13.85% |
| WACC | 13.8% |